Follow
Dwi Utami Kemaladewi
Dwi Utami Kemaladewi
University of Pittsburgh School of Medicine & UPMC Children’s Hospital of Pittsburgh
Verified email at pitt.edu - Homepage
Title
Cited by
Cited by
Year
Expanding the boundaries of RNA sequencing as a diagnostic tool for rare Mendelian disease
HD Gonorazky, S Naumenko, AK Ramani, V Nelakuditi, P Mashouri, ...
The American Journal of Human Genetics 104 (3), 466-483, 2019
2592019
Spell checking nature: versatility of CRISPR/Cas9 for developing treatments for inherited disorders
D Wojtal, DU Kemaladewi, Z Malam, S Abdullah, TWY Wong, E Hyatt, ...
The American Journal of Human Genetics 98 (1), 90-101, 2016
1322016
A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene
DU Kemaladewi, PS Bassi, S Erwood, D Al-Basha, KI Gawlik, K Lindsay, ...
Nature 572 (7767), 125-130, 2019
1202019
Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism
DU Kemaladewi, E Maino, E Hyatt, H Hou, M Ding, KM Place, X Zhu, ...
Nature medicine 23 (8), 984-989, 2017
872017
Lethal disorder of mitochondrial fission caused by mutations in DNM1L
G Yoon, Z Malam, T Paton, CR Marshall, E Hyatt, Z Ivakine, SW Scherer, ...
The Journal of pediatrics 171, 313-316. e2, 2016
772016
Cell‐type specific regulation of myostatin signaling
DU Kemaladewi, DJJ de Gorter, A Aartsma‐Rus, GJ van Ommen, P Dijke, ...
The FASEB Journal 26 (4), 1462-1472, 2012
752012
Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy
DU Kemaladewi, WMH Hoogaars, SH van Heiningen, S Terlouw, ...
BMC medical genomics 4, 1-10, 2011
672011
BMP antagonists enhance myogenic differentiation and ameliorate the dystrophic phenotype in a DMD mouse model
ST Shi, WMH Hoogaars, DJJ de Gorter, SH van Heiningen, HY Lin, ...
Neurobiology of disease 41 (2), 353-360, 2011
462011
Antisense-oligonucleotide mediated exon skipping in activin-receptor-like kinase 2: inhibiting the receptor that is overactive in fibrodysplasia ossificans progressiva
ST Shi, J Cai, DJJ de Gorter, G Sanchez-Duffhues, DU Kemaladewi, ...
PloS one 8 (7), e69096, 2013
442013
ATP8A1 activity and phosphatidylserine transbilayer movement
E Soupene, D Utami Kemaladewi, FA Kuypers
Journal of receptor, ligand and channel research, 1-10, 2008
392008
Targeting TGF-β signaling by antisense oligonucleotide-mediated knockdown of TGF-β type I receptor
DU Kemaladewi, S Pasteuning, JW Van Der Meulen, SH Van Heiningen, ...
Molecular Therapy-Nucleic Acids 3, 2014
342014
Novel ex vivo culture method for the study of Dupuytren's disease: effects of TGFβ type 1 receptor modulation by antisense oligonucleotides
S Karkampouna, BPT Kruithof, P Kloen, MC Obdeijn, AM Van Der Laan, ...
Molecular Therapy-Nucleic Acids 3, 2014
332014
Increased polyamines as protective disease modifiers in congenital muscular dystrophy
DU Kemaladewi, JS Benjamin, E Hyatt, EA Ivakine, RD Cohn
Human molecular genetics 27 (11), 1905-1912, 2018
172018
Exon snipping in Duchenne muscular dystrophy
DU Kemaladewi, RD Cohn
Trends in Molecular Medicine 22 (3), 187-189, 2016
132016
TGF-β signaling in Duchenne muscular dystrophy
DU Kemaladewi, PA ‘t Hoen, P Ten Dijke, GJ Van Ommen, WM Hoogaars
Future Neurology 7 (2), 209-224, 2012
62012
CRISPRa-induced upregulation of human LAMA1 compensates for LAMA2-deficiency in merosin-deficient congenital muscular dystrophy
AI Arockiaraj, MA Johnson, A Munir, P Ekambaram, PC Lucas, ...
bioRxiv, 2023
32023
Merosin deficient congenital muscular dystrophy type 1A: An international workshop on the road to therapy 15-17 November 2019, Maastricht, the Netherlands
HJM Smeets, B Verbrugge, P Springuel, NC Voermans, G Cossu, ...
Neuromuscular Disorders 31 (7), 673-680, 2021
32021
A mutation-independent approach via transcriptional upregulation of a disease modifier gene rescues muscular dystrophy in vivo
DU Kemaladewi, PS Bassi, K Lindsay, S Erwood, E Hyatt, KM Place, ...
bioRxiv, 286500, 2018
32018
CRISPR/Cas9-mediated exon inclusion in Lama2 gene alleviates dystrophic pathology in MDC1A mouse model
D Kemaladewi, E Hyatt, Z Ivakine, R Cohn
Neuromuscular Disorders 26, S190, 2016
32016
Impaired polyamine metabolism causes behavioral and neuroanatomical defects in a mouse model of Snyder–Robinson syndrome
O Akinyele, A Munir, MA Johnson, MS Perez, Y Gao, JR Foley, A Nwafor, ...
Disease Models & Mechanisms 17 (6), dmm050639, 2024
12024
The system can't perform the operation now. Try again later.
Articles 1–20